CENTRAL AND PERIPHERAL EFFECT OF MPTP VIA DOSE-DEPENDENT MAGNESIUM MODULATION

R Lefter1, I M Balmus2, A Ciobica1,3,4

  • 1Centre of Biomedical Research, Romanian Academy, Iasi, Romania.

Acta Endocrinologica (Bucharest, Romania : 2005)
|August 21, 2023
PubMed
Abstract

Insights

MPTP causes constipation and behavioral changes in rats, which are worsened by low magnesium. Magnesium intake may mitigate these MPTP-induced effects, highlighting its role beyond the central nervous system.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Toxicology

Background:

  • MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) may induce gastrointestinal motility deficits and central nervous system (CNS) effects.
  • Magnesium's neuroprotective, gastrointestinal, and antioxidant roles suggest a potential interaction with MPTP-induced impairments.

Purpose of the Study:

  • To investigate the modulatory effects of varied magnesium intake on MPTP neurotoxicity.
  • To assess magnesium's impact on MPTP-induced functional gastrointestinal impairments.

Main Methods:

  • Rats received magnesium-controlled diets and enriched drinking water before MPTP administration.
  • Gastrointestinal motility, behavioral patterns (Y maze, elevated plus maze, open field, forced swim tests), and oxidative stress markers in brain and bowel were evaluated.

Main Results:

  • MPTP induced magnesium intake-dependent constipation, anxiety- and depressive-like behaviors, and altered pain tolerance.
  • Magnesium-dependent oxidative stress was observed in both brain and intestinal tissues.

Conclusions:

  • MPTP's systemic effects extend beyond the CNS to the gastrointestinal system.
  • Magnesium intake may play a crucial role in mitigating MPTP-induced abnormalities, suggesting its importance in managing neurotoxin-related conditions.